Table 3.
Median SCFA Values at Baseline and After One Year of IFNβ Treatment
| AA (µM) | PA (µM) | BA (µM) | CA (µM) | BA/CA ratio | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Median | 95% CI | Median | 95% CI | Median | 95% CI | Median | 95% CI | Median | 95% CI | |
| Baseline | 23.12 | [15.84; 43.82] | 7.250 | [4.32; 7.87] | 7.63 | [2.70; 9.64] | 1.64 | [1.47; 2.59] | 2.44 | [1.02; 5.54] | 
| After one year of IFNβ treatment | 21.10 | [15.71; 22.53] | 4.500 | [3.88; 5.40] | 5.19 | [3.19; 6.09] | 1.98 | [1.37; 2.21] | 2.3 | [1.27; 4.03] | 
| p-value | 0.11 | 0.06 | 0.15 | 0.41 | 0.84 | |||||
Abbreviations: AA, acetic acid; PA, propionic acid; BA, butyric acid; CA, caproic acid, IFNβ, interferon beta. Wilcoxon matched-pairs signed rank test.